41 results
8-K
EX-2.1
ODYY
Odyssey Group International, Inc.
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
by this Agreement. 4.27.2. The Company is not a party to, nor or has any commitment to become a party to, (i) any joint venture, off-balance sheet … , the Company will not, without the prior written consent of Purchaser: (a) enter into any Contract or commitment related to the Business, the Purchased
8-K
EX-10.2
ODYY
Odyssey Group International, Inc.
18 Aug 23
Entry into a Material Definitive Agreement
5:10pm
and an underwriter as a part of a secondary offering. The Borrower will notify Lender of such an offering, and Lender shall respond with a firm commitment
8-K
EX-99.1
elrvbtg
4 Nov 22
Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team
4:16pm
8-K
xc8t0w5kit78k4ps5k
4 Nov 22
Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team
4:16pm
424B3
6yc35zzv2w1bsphduzqz
9 Aug 22
Prospectus supplement
9:26am
8-K
EX-99.1
vjx83c46u2ezpd hfz
20 Apr 22
Regulation FD Disclosure
5:15pm